JAK, Inhibitors JAK Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in the Domain 07.08.2025 - 18:04:48 | prnewswire.co.uk DelveInsight Business Research, LLP United States of America United Kingdom View original content:https://www.prnewswire.co.uk/news-releases/jak-inhibitors-clinical-trial-pipeline-experiences-momentum-delveinsight-estimates-a-diverse-pipeline-comprising-50-companies-working-in-the-domain-302282579.html en | boerse | 67979926 |
